Skip to main content
Year archive

argenx SE — 2020 filings

All 50 regulatory filings released by argenx SE (1AE) in 2020, sourced directly from the official regulator.

50 Filings
2020 Period
2020 filings (50)
Filing Released Lang
FORM 6-K
Foreign Filer Report
2020-11-23 English
argenx Enters Into Agreement To Acquire Priority Review Voucher
Capital/Financing Update
2020-11-23 English
argenx to Participate in Upcoming Virtual Investor Conferences
Report Publication Announcement
2020-11-09 English
FORM 6-K
Foreign Filer Report
2020-10-22 English
argenx Reports Third Quarter 2020 Financial Results and Provides Business Update
Earnings Release 9M 2020
2020-10-22 English
argenx to Report Third Quarter 2020 Financial Results and Business Update on October 22, 2020
Report Publication Announcement
2020-10-15 English
FORM 6-K
Foreign Filer Report
2020-10-06 English
argenx Expands Capabilities In Antibody Engineering Through Key Technology Partnerships
Regulatory Filings
2020-10-06 English
argenx Presents Additional Efgartigimod Data from Global Phase 3 ADAPT Trial at the Myasthenia Gravis Foundation of America 2020 Scientific Session
Investor Presentation
2020-10-05 English
argenx to Present Additional Data from Global Phase 3 ADAPT Trial of Efgartigimod for Myasthenia Gravis at Upcoming Virtual Medical Meetings
Regulatory Filings
2020-09-18 English
argenx Management to Present at Upcoming Virtual Investor Conferences
Report Publication Announcement
2020-09-02 English
argenx to Present at 2020 Wedbush PacGrow Healthcare Virtual Conference
Regulatory Filings
2020-08-04 English
6-K
Foreign Filer Report
2020-07-31 English
Interim / Quarterly Report 2020
Interim / Quarterly Report H1 2020
2020-07-31 English
FORM 6-K
Foreign Filer Report
2020-07-30 English
argenx reports half year 2020 financial results and provides second quarter business update
Interim / Quarterly Report H1 2020
2020-07-30 English
argenx to report half year 2020 financial results and second quarter business update on July 30, 2020
Report Publication Announcement
2020-07-23 English
Major Shareholding Notification 2020
Major Shareholding Notification
2020-06-10 English
Major Shareholding Notification 2020
Major Shareholding Notification
2020-06-10 English
argenx to Present at Goldman Sachs 41st Annual Global Healthcare Conference
Regulatory Filings
2020-06-04 English
argenx announces closing of global offering
Share Issue/Capital Change
2020-06-02 English
FORM 6-K
Foreign Filer Report
2020-05-29 English
424B5
Prospectus
2020-05-29 English
argenx announces full exercise of underwriters’ option to purchase additional ADSs
Share Issue/Capital Change
2020-05-29 English
argenx raises $750 million in gross proceeds in a global offering
Capital/Financing Update
2020-05-28 English
argenx announces launch of proposed global offering
Capital/Financing Update
2020-05-27 English
424B5
Prospectus
2020-05-26 English
FORM 6-K
Foreign Filer Report
2020-05-26 English
argenx Announces Positive Topline Results from Phase 3 ADAPT Trial of Efgartigimod in Patients with Generalized Myasthenia Gravis
Earnings Release Q2 2020
2020-05-26 English
FORM 6-K
Foreign Filer Report
2020-05-14 English
argenx reports first quarter 2020 financial results and provides business update
Earnings Release Q1 2020
2020-05-14 English
FORM 6-K
Foreign Filer Report
2020-05-12 English
argenx announces results of Annual General Meeting of Shareholders
AGM Information
2020-05-12 English
argenx to Present Data from Phase 2 Trial of Efgartigimod in Pemphigus at 2020 Society for Investigative Dermatology (SID) Virtual Annual Meeting
Investor Presentation
2020-05-08 English
argenx to report first quarter 2020 financial results and business update on May 14, 2020
Earnings Release Q1 2020
2020-05-07 English
argenx to Present at BofA Securities Virtual Health Care Conference 2020
Report Publication Announcement
2020-05-06 English
Regulatory Filings 2020
Regulatory Filings
2020-04-29 English
20-F
Annual Report FY 2019
2020-03-31 English
6-K
Foreign Filer Report
2020-03-31 English
argenx announces Annual General Meeting of Shareholders on May 12, 2020
AGM Information
2020-03-31 English
FORM 6-K
Foreign Filer Report
2020-02-27 English
argenx reports full year 2019 financial results and provides fourth quarter business update
Annual Report FY 2019
2020-02-27 English
argenx reports full year 2019 financial results and provides fourth quarter business update
Earnings Release FY 2019
2020-02-27 English
argenx to Present at Cowen 40th Annual Health Care Conference
Regulatory Filings
2020-02-25 English
argenx to report full year 2019 financial results and fourth quarter business update on February 27, 2020
Report Publication Announcement
2020-02-20 English
Major Shareholding Notification 2020
Major Shareholding Notification
2020-02-14 English
Major Shareholding Notification 2020
Major Shareholding Notification
2020-02-07 English
6-K
Foreign Filer Report
2020-01-13 English
6-K
Foreign Filer Report
2020-01-09 English
argenx Provides Strategic Outlook Advancing Late-Stage Pipeline Towards ‘argenx 2021’ Vision
Earnings Release FY 2019
2020-01-09 English